Related references
Note: Only part of the references are listed.Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74
Philip S. Miller et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus
Anna P. Andreou et al.
NEUROBIOLOGY OF DISEASE (2010)
Randomized, controlled trial of telcagepant for the acute treatment of migraine
K. M. Connor et al.
NEUROLOGY (2009)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion
Zhongming Zhang et al.
JOURNAL OF NEUROSCIENCE (2007)
Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: A migraine target?
Kevin G. Shields et al.
NEUROBIOLOGY OF DISEASE (2006)
A positron emission tomographic study in spontaneous migraine
SK Afridi et al.
ARCHIVES OF NEUROLOGY (2005)
The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus
MJM Fischer et al.
JOURNAL OF NEUROSCIENCE (2005)
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
KG Shields et al.
BRAIN (2005)
Somatosensory evoked high-frequency oscillations reflecting thalamo-cortical activity are decreased in migraine patients between attacks
G Coppola et al.
BRAIN (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat
RJ Storer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels
S Akerman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists
JJ Mallee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Drug therapy: Migraine - Current understanding and treatment.
PJ Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:: a meta-analysis of 53 trials
MD Ferrari et al.
LANCET (2001)
Cloning, characterization and distribution of receptor activity central nervous system modifying proteins in the rat
KR Oliver et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
RB Lipton et al.
HEADACHE (2001)
Vascular dementia: A cognitive SPET-CBF activation study
V Di Piero et al.
CEREBROVASCULAR DISEASES (2001)
Tbe development of cutaneous allodynia during a migraine attack - Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine
R Burstein et al.
BRAIN (2000)
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
H Doods et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
The global burden of disease study - Implications for neurology
M Menken et al.
ARCHIVES OF NEUROLOGY (2000)
Share Paper
